Cullinan Therapeutics, Inc.

CGEM

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001789972

SEC filings (opens in a new tab)

In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Cullinan Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of CGEM: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	137	1	147	+11
Shares	65.0M	26	65.6M	+579.9K (+0.9%)
Value	$1.09B	$453	$798.8M	−$288.2M (−26.5%)

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to CGEM in Q4 2024
Institution	Shares	Value	% of portfolio
Kynam Capital Management, LP	1,252,738	$15.3M	1.01%
Boxer Capital Management, LLC	907,895	$11.1M	0.94%
Foresite Capital Management VI LLC	634,558	$7.73M	3.44%
Springhill Fund Asset Management (HK) Co Ltd	276,400	$3.37M	5.47%
Woodline Partners LP	167,315	$2.04M	0.01%
Cubist Systematic Strategies, LLC	130,647	$1.59M	0.03%
Voss Capital, LLC	122,361	$1.49M	0.11%
BNP Paribas Arbitrage, SA	115,000	$1.40M	0.00%
Kennedy Capital Management, Inc.	111,049	$1.35M	0.03%
BIT Capital GmbH	94,344	$1.15M	0.10%
XTX Topco Ltd	43,399	$528.6K	0.04%
Tema ETFs LLC	28,433	$346.3K	0.14%
ExodusPoint Capital Management, LP	23,500	$286.0K	0.00%
Connor, Clark & Lunn Investment Management Ltd.	20,273	$246.9K	0.00%
Brevan Howard Capital Management LP	14,735	$179.5K	0.00%
EntryPoint Capital, LLC	14,657	$178.5K	0.08%
Qube Research & Technologies Ltd	13,609	$165.8K	0.00%
Corton Capital Inc.	11,944	$145.5K	0.08%
Optimize Financial Inc	11,755	$143.2K	0.11%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management	11,153	$135.8K	0.00%
Police & Firemen's Retirement System of New Jersey	10,582	$128.9K	0.00%
KLP Kapitalforvaltning AS	6,800	$82.8K	0.00%
Aquatic Capital Management LLC	6,357	$77.4K	0.00%
Point72 (DIFC) Ltd	5,986	$72.9K	0.01%
GF Fund Management Co. Ltd.	1,223	$14.9K	0.00%
BFSG, LLC	1,000	$12.2K	0.00%
Advisor Group Holdings, Inc.	110	$1.34K	0.00%
Amundi	40	$445	0.00%
Group One Trading, L.P.	16	$195	0.00%
IFP Advisors, Inc	0	$110	0.00%
SBI Securities Co., Ltd.	1	$12	0.00%

Sold out (20)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of CGEM in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Paradigm Biocapital Advisors LP	2,321,013	$38.9M
Holocene Advisors, LP	1,533,579	$25.7M
Boxer Capital, LLC	907,895	$15.2M
Avidity Partners Management LP	425,000	$7.11M
PFM Health Sciences, LP	182,810	$3.06M
Ensign Peak Advisors, Inc	148,773	$2.49M
ADAR1 Capital Management, LLC	54,358	$910.0K
Verition Fund Management LLC	36,624	$613.1K
Y-Intercept (Hong Kong) Ltd	25,369	$424.7K
Caption Management, LLC	23,000	$385.0K
Superstring Capital Management LP	20,840	$348.9K
Quest Partners LLC	20,404	$341.6K
Engineers Gate Manager LP	12,245	$205.0K
Arizona State Retirement System	10,788	$180.6K
Acadian Asset Management LLC	956	$16.0K
nVerses Capital, LLC	600	$10.0K
Bessemer Group Inc	105	$2.00K
Rothschild Investment LLC	60	$1.00K
Capital Performance Advisors LLP	13	$218
SRS Capital Advisors, Inc.	7	$118

Not filed for Q4 2024 yet (1)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CGEM in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
ClariVest Asset Management LLC	26	$453